Conversion to Everolimus-Based Immunosuppression Regimen with Calcineurin Inhibitor Reduction Ameliorates Histological Damage in Kidney Transplant Recipients with Calcineurin Inhibitor-Induced Nephrotoxicity.

被引：0
|
作者：
Hotta, K. [1 ]
Iwahara, N. [1 ]
Tanabe, T. [1 ]
Shinohara, N. [1 ]
机构：
[1] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D178
引用
收藏
页码：1083 / 1083
页数：1
相关论文
共 50 条
  • [1] Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients
    Manzia, T. M.
    Angelico, R.
    Toti, L.
    Grimaldi, C.
    Sforza, D.
    Vella, I.
    Tariciotti, L.
    Lenci, I.
    Breshanaj, G.
    Baiocchi, L.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 175 - 183
  • [2] Chronic calcineurin inhibitor-induced nephrotoxicity in kidney transplant recipients: histological markers not so specific
    Rabant, M.
    Snanoudj, R.
    Royal, V.
    Girardin, C.
    Morelon, E.
    Legendre, C.
    Noel, L. -H.
    VIRCHOWS ARCHIV, 2011, 459 : S46 - S46
  • [3] Conversion to Everolimus in Kidney Transplant Recipients With Calcineurin Inhibitor-Induced Nephropathy: 3 Case Reports
    Nanmoku, Koji
    Shinzato, Takahiro
    Kubo, Taro
    Shimizu, Toshihiro
    Yagisawa, Takashi
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (05) : 1424 - 1427
  • [4] EVEROLIMUS-BASED IMMUNOSUPPRESSION TO REVERSE CALCINEURIN-INHIBITOR-ASSOCIATED MYOPATHIC SYMPTOMS IN HEART TRANSPLANT RECIPIENTS
    Meyer, S.
    Deuse, T.
    Baholli, L.
    Sattinger, E.
    Schlueter, M.
    von Stritzky, A.
    Reichenspurner, H.
    Costard-Jaeckle, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 46 - 47
  • [5] CONVERSION FROM CALCINEURIN INHIBITOR-BASED TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS: LONG-TERM OUTCOME
    Dayangac, Murat
    TRANSPLANT INTERNATIONAL, 2017, 30 : 363 - 363
  • [6] Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
    Ivulich, Steven
    Paul, Eldho
    Kirkpatrick, Carl
    Dooley, Michael
    Snell, Greg
    TRANSPLANT INTERNATIONAL, 2023, 36
  • [7] Predictors of Graft Function Improvement after Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Calcineurin Inhibitor Nephrotoxicity.
    Viglietti, D.
    Pievani, D.
    Louis, K.
    Glotz, D.
    Legendre, C.
    Loupy, A.
    Lefaucheur, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 450 - 450
  • [8] Reduction of Tacrolimus With Everolimus Addition in Maintenance Immunosuppression Improves Calcineurin Inhibitor-Induced Arteriolopathy in Kidney Allografts
    Miura, M.
    Higashiyama, H.
    Fukasawa, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [9] Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts
    Miura, Masayoshi
    Higashiyama, Hiroshi
    Fukasawa, Yuichiro
    Itoh, Yosuke
    Tamaki, Tohru
    NEPHROLOGY, 2015, 20 : 58 - 60
  • [10] Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression
    Peddi, V. Ram
    Marder, Bradley
    Gaite, Luis
    Oberholzer, Jose
    Goldberg, Ryan
    Pearson, Thomas
    Yang, Harold
    Allamassey, Lisa
    Polinsky, Martin
    Formica, Richard N.
    TRANSPLANTATION DIRECT, 2023, 9 (02): : E1419
12345